DermTech Inc (DMTK)
0.50
-0.07
(-12.45%)
USD |
NASDAQ |
May 17, 16:00
0.50
0.00 (0.00%)
After-Hours: 20:00
DermTech Revenue (Quarterly): 3.924M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.924M |
| September 30, 2023 | 3.915M |
| June 30, 2023 | 3.98M |
| March 31, 2023 | 3.477M |
| December 31, 2022 | 2.994M |
| September 30, 2022 | 3.573M |
| June 30, 2022 | 4.233M |
| March 31, 2022 | 3.718M |
| December 31, 2021 | 3.165M |
| Date | Value |
|---|---|
| September 30, 2021 | 3.03M |
| June 30, 2021 | 3.119M |
| March 31, 2021 | 2.524M |
| December 31, 2020 | 2.121M |
| September 30, 2020 | 1.362M |
| June 30, 2020 | 0.844M |
| March 31, 2020 | 1.557M |
| December 31, 2019 | 1.589M |
| September 30, 2019 | 0.565M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.565M
Minimum
Sep 2019
4.233M
Maximum
Jun 2022
2.761M
Average
3.074M
Median
Revenue (Quarterly) Benchmarks
| RadNet Inc | 431.71M |
| iSpecimen Inc | 2.29M |
| 23andMe Holding Co | 44.75M |
| Sera Prognostics Inc | -- |
| Progyny Inc | 278.08M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.09M |
| Total Expenses (Quarterly) | 23.68M |
| EPS Diluted (Quarterly) | -0.56 |
| Enterprise Value | -38.40M |
| Gross Profit Margin (Quarterly) | 11.21% |
| Profit Margin (Quarterly) | -486.5% |
| Earnings Yield | -628.6% |
| Normalized Earnings Yield | -628.66 |